Brainvectis is a startup based in France, 1 tracked investor.
Brainvectis is a company headquartered in France. Brouky records 1 investor associated with the company.
Brainvectis is a French biotech company developing innovative gene therapies for neurodegenerative diseases, with a primary focus on Huntington's disease. It originated as a spin-off from the French Alternative Energies and Atomic Energy Commission (CEA) and the University of Paris-Saclay.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.